Clinical utility of in vitro evaluation of granulopoiesis.
D000380:Agranulocytosis / Q000097:blood*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D002455:Cell Division; D002999:Clone Cells; D004247:DNA / Q000096:biosynthesis; D004731:Endotoxins / Q000494:pharmacology; D005258:Felty Syndrome / Q000097:blood; D006023:Glycoproteins / Q000037:antagonists & inhibitors / Q000097:blood / Q000502:physiology / Q000652:urine; D006412:Hematopoietic Stem Cells / Q000378:metabolism; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood; D007962:Leukocytes; D051379:Mice; D009196:Myeloproliferative Disorders / Q000097:blood*; D009504:Neutrophils / Q000378:metabolism; D011230:Precancerous Conditions / Q000097:blood; D012075:Remission, Spontaneous; D013268:Stimulation, Chemical
D000970:Antineoplastic Agents; D004731:Endotoxins; D006023:Glycoproteins; D004247:DNA